Table 1 Clinical characteristics of the included COVID-19 patients.
Characteristics | All patients (n = 567) | AST/ALT < 1.38 (n = 367) | AST/ALT ≥ 1.38 (n = 200) | P Value |
|---|---|---|---|---|
Age, median (IQR), years | 55 (37–67) | 51 (37–64) | 60 (37.3–71) | 0.001* |
Sex | 0.278 | |||
Male | 247 (43.6) | 166 (45.2) | 81 (40.5) | |
Female | 320 (56.4) | 201 (54.8) | 119 (59.5) | |
Time | ||||
Illness onset to hospital admission, median (IQR), days | 7 (4–10) | 7 (4–10) | 7 (3–9) | 0.059 |
Signs and symptoms | ||||
Fever | 455 (80.2) | 293 (79.8) | 162 (81) | 0.74 |
Myalgia | 143 (25.2) | 79 (21.5) | 64 (32) | 0.006* |
Fatigue | 208 (36.7) | 117 (31.9) | 91 (45.5) | 0.001* |
Headache | 36 (6.3) | 22 (6) | 14 (7) | 0.639 |
Cough | 370 (65.3) | 238 (64.9) | 132 (66) | 0.784 |
Chest tightness | 222 (39.2) | 144 (39.2) | 78 (39) | 0.956 |
Chest pain | 27 (4.8) | 19 (5.2) | 8 (4) | 0.529 |
Diarrhea | 51 (9) | 33 (9) | 18 (9) | 0.997 |
Comorbidities | ||||
Any | 250 (44.1) | 154 (42) | 96 (48) | 0.166 |
COPD | 36 (6.3) | 17 (3) | 19 (9.5) | 0.023* |
Hypertension | 183 (32.3) | 115 (31.3) | 68 (34) | 0.517 |
Diabetes | 85 (15) | 50 (13.6) | 35 (17.5) | 0.217 |
Cardiovascular disease | 53 (9.3) | 25 (6.8) | 28 (14) | 0.005* |
Cerebrovascular disease | 32 (5.6) | 16 (4.4) | 16 (8) | 0.073 |
Chronic kidney disease | 31 (5.5) | 12 (3.3) | 19 (9.5) | 0.002* |
≥ 2 comorbidities co-exist | 108 (19) | 58 (15.8) | 50 (25) | 0.008* |
Outcomes | ||||
Recovery and discharge | 490 (86.4) | 336 (91.6) | 154 (77) | < 0.001* |
Death | 65 (11.5) | 24 (6.5) | 41 (20.5) | < 0.001* |
Transfer to specialized hospitals | 12 (2.1) | 7 (1.9) | 5 (2.5) | 0.87 |
